AU Patent

AU2015289035B2 — Aqueous formulation comprising paracetamol and ibuprofen

Assigned to Everbright Pharmaceuticals SARL · Expires 2020-03-26 · 6y expired

What this patent protects

The present invention relates to an aqueous ibuprofen and paracetamol composition of pH 6.3-7.3and to its use. The present invention relates to a method for preparing a combination product of ibuprofen and paracetamol. It also relates to the compositions for use as a medicament, …

USPTO Abstract

The present invention relates to an aqueous ibuprofen and paracetamol composition of pH 6.3-7.3and to its use. The present invention relates to a method for preparing a combination product of ibuprofen and paracetamol. It also relates to the compositions for use as a medicament, especially for the treatment of pain and/or inflammation;especially for administration of the composition by intravenous injection.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015289035B2
Jurisdiction
AU
Classification
—
Expires
2020-03-26
Drug substance claim
No
Drug product claim
No
Assignee
Everbright Pharmaceuticals SARL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.